Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
BioPharma Trends, 41(5), 589-612
Effects of Low-Dose, Controlled-Release Phentermine Plus Topiramate Combination on Weight and Associated Comorbidities in Overweight and Obese Adults (CONQUER): A Randomised, Placebo-Controlled, Phase 3 Trial
Prescription access is not expected until late 2027 at the earliest, with mid-2028 being more realistic under standard FDA review timelines
Many patients can begin after their first consultation once the provider confirms the treatment is appropriate
A single vial covers exactly 5 days at the prescribed 20 units per dose
US$ 26.23
US$ 23.13
US$ 22.43
US$ 26.76
US$ 23.02
US$ 21.24
